Skip to main navigation Skip to search Skip to main content

Liquid biopsies in pediatric oncology: opportunities and obstacles

  • National Institutes of Health

Research output: Contribution to journal › Review article › peer-review

23 Scopus citations

Abstract

Purpose of review Liquid biopsies have emerged as a noninvasive alternative to tissue biopsy with potential applications during all stages of pediatric oncology care. The purpose of this review is to provide a survey of pediatric cell-free DNA (cfDNA) studies, illustrate their potential applications in pediatric oncology, and to discuss technological challenges and approaches to overcome these hurdles. Recent findings Recent literature has demonstrated liquid biopsies' ability to inform treatment selection at diagnosis, monitor clonal evolution during treatment, sensitively detect minimum residual disease following local control, and provide sensitive posttherapy surveillance. Advantages include reduced procedural anesthesia, molecular profiling unbiased by tissue heterogeneity, and ability to track clonal evolution. Challenges to wider implementation in pediatric oncology, however, include blood volume restrictions and relatively low mutational burden in childhood cancers. Multiomic approaches address challenges presented by low-mutational burden, and novel bioinformatic analyses allow a single assay to yield increasing amounts of information, reducing blood volume requirements. Summary Liquid biopsies hold tremendous promise in pediatric oncology, enabling noninvasive serial surveillance with adaptive care. Already integrated into adult care, recent advances in technologies and bioinformatics have improved applicability to the pediatric cancer landscape.

Original languageEnglish
Pages (from-to)39-47
Number of pages9
JournalCurrent Opinion in Pediatrics
Volume34
Issue number1
DOIs
StatePublished - 1 Feb 2022
Externally publishedYes

Keywords

  • Biomarkers
  • Cell-free DNA
  • Circulating DNA
  • Liquid biopsy

Fingerprint

Dive into the research topics of 'Liquid biopsies in pediatric oncology: opportunities and obstacles'. Together they form a unique fingerprint.

Cite this